News
1d
MedPage Today on MSNNew Guideline Puts Some at the Front of the Line for GLP-1, SGLT2 Drugs
No blanket recommendation can be made for SGLT2 inhibitors and GLP-1 receptor agonists in adults with type 2 diabetes (T2D) ...
Adults with type 2 diabetes who initiate SGLT2 inhibitors within 3 months of a diagnosis of a urinary tract infection have a ...
Canagliflozin is generally well tolerated and improves blood sugar control in children and adolescents with type 2 diabetes, ...
Children and adolescents with type 2 diabetes had greater reductions in HbA1c with an oral SGLT2 inhibitor compared with ...
Germany: A retrospective cohort study has found that prior use of SGLT2 inhibitors in type 2 diabetes mellitus (T2DM) ...
This latest approval builds on an earlier liquid formulation of generic methimazole for feline hyperthyroidism, which ...
There is lower risk for recurrent HF hospitalization in older patients that receive SGLT2is following acute decompensated heart failure.
A new observational study shows that sodium-glucose co-transporter 2 (SGLT2) inhibitors are associated with reduced risk of cardiovascular mortality, heart failure, and chronic kidney disease in ...
Polyuria and polydipsia (PU/PD)—excessive urination and thirst/drinking—are common concerns in cats with diabetes.
With SGLT2 inhibitors, the first pill you swallow works — the response is measured in hours. The only adverse effect to discuss is risk for genital mycotic infections, which can be mitigated.
Additionally, SGLT2 inhibitors vs placebo were associated with a lower incidence of MACE (RR, 0.88; 95% CI, 0.79-0.97; P =.012) but did not significantly affect MI, cardiovascular, or all-cause ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results